Adaptive Biotechnologies Corp vs Paycom Software Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Paycom Software Inc trades at $211 (market cap $9.57B). The key difference: Paycom Software Inc is far larger — about 2.4× Adaptive Biotechnologies Corp's market cap, and Paycom Software Inc pays a 0.71% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | PAYC | |
|---|---|---|
Market Cap | $4.04B | $9.57B |
Sector | Health | Technology |
52-Week High | $25.45 | $233.89 |
52-Week Low | $12.30 | $113.59 |
Enterprise Value | $4.10B | $10.35B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →